share_log

12 Health Care Stocks Moving In Friday's Intraday Session

Benzinga ·  Mar 15 13:31

Gainers

  • Better Therapeutics (NASDAQ:BTTX) shares increased by 65.4% to $0.06 during Friday's regular session. The market value of their outstanding shares is at $3.1 million.
  • Carmell (NASDAQ:CTCX) shares rose 38.52% to $3.2. The market value of their outstanding shares is at $73.8 million.
  • P3 Health Partners (NASDAQ:PIII) stock rose 38.23% to $0.98. The market value of their outstanding shares is at $112.5 million.
  • Akebia Therapeutics (NASDAQ:AKBA) shares rose 28.1% to $1.75. The market value of their outstanding shares is at $330.6 million. The company's, Q4 earnings came out yesterday.
  • Acrivon Therapeutics (NASDAQ:ACRV) shares increased by 26.03% to $6.39. The market value of their outstanding shares is at $141.8 million.
  • DIH Holding US (NASDAQ:DHAI) stock rose 21.22% to $1.28. The market value of their outstanding shares is at $52.1 million.

Losers

  • SELLAS Life Sciences Gr (NASDAQ:SLS) shares decreased by 28.7% to $1.1 during Friday's regular session. The company's market cap stands at $48.0 million.
  • Immuneering (NASDAQ:IMRX) shares fell 28.45% to $2.08. The company's market cap stands at $60.7 million.
  • Lucy Scientific Discovery (NASDAQ:LSDI) stock decreased by 25.64% to $1.24. The market value of their outstanding shares is at $2.1 million.
  • Atreca (NASDAQ:BCEL) stock fell 17.54% to $0.16. The market value of their outstanding shares is at $6.5 million.
  • Jin Medical International (NASDAQ:ZJYL) shares fell 17.3% to $4.4. The market value of their outstanding shares is at $688.8 million.
  • Psyence Biomedical (NASDAQ:PBM) stock declined by 17.3% to $1.31. The market value of their outstanding shares is at $17.6 million.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment